• Piezo1 Triggers PANoptosis in Cardiac Ischaemia/Reperfusion

  2026-08-07

  This study demonstrates that the mechanosensitive ion channel Piezo1 is a key driver of myocardial ischaemia/reperfusion (I/R) injury by activating caspase-8-mediated PANoptosis in cardiomyocytes. The findings identify Piezo1 as a novel mechanosensor linking mechanical stress to complex cell death pathways, highlighting a promising therapeutic target for ischaemic heart disease.

• Nutlin-3a (SKU A3671): Reliable MDM2 Inhibitor for Cancer Re

  2026-08-06

  This article provides a scenario-driven, evidence-based guide to using Nutlin-3a (SKU A3671) in cell viability, proliferation, and apoptosis assays. By contextualizing real-world laboratory challenges, it demonstrates how Nutlin-3a’s validated performance and workflow compatibility support reproducible, data-backed cancer research outcomes.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution

  2026-08-06

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a straightforward approach for nuclear visualization, cell viability assessment, and apoptosis detection in fixed or membrane-compromised cells. It should not be used for live-cell imaging due to its limited cell permeability, but is optimized for use in fluorescence microscopy and flow cytometry protocols.

• Bufalin: Mechanisms and Benchmarks in Cancer Research

  2026-08-05

  Bufalin is a cardiotonic steroid that induces apoptosis and cell differentiation in cancer cells, notably via AP-1 activation pathways. As a molecular glue degrader of estrogen receptor alpha and a validated STK33 inhibitor, Bufalin demonstrates potent activity in triple-negative breast cancer models. This dossier details its mechanisms, evidence, and research utility.

• Trelagliptin succinate (SKU A3889): Reliable Solutions for D

  2026-08-05

  This scenario-driven guide demonstrates how Trelagliptin succinate (SKU A3889) addresses laboratory challenges in diabetes mellitus research, osteoblastic differentiation, and cytotoxicity workflows. Drawing on validated data and peer-reviewed studies, it provides practical, evidence-based recommendations for assay optimization and vendor selection. Researchers can rely on APExBIO’s Trelagliptin succinate for reproducibility and data integrity across diverse experimental models.

• Axitinib (AG 013736): Precision Tools for Angiogenesis Assay

  2026-08-04

  Axitinib (AG 013736) delivers unmatched selectivity and potency for dissecting VEGF signaling in cancer biology research. Explore protocol-driven workflows, troubleshooting insights, and practical guidance for maximizing reproducibility in angiogenesis and tumor growth inhibition studies.

• Viperin Inhibits Coronavirus Replication by Disrupting nsp8–

  2026-08-04

  This study uncovers a conserved mechanism by which the interferon-induced enzyme viperin restricts coronavirus replication. By targeting non-structural protein 8 (nsp8) and disrupting the assembly of the replication-transcription complex, viperin impairs viral RNA synthesis, revealing new antiviral intervention points and clarifying the dual role of viperin in both ddhCTP production and direct RTC inhibition.

• Phos binding reagent (Phosbind) acrylamide: Reliable Phospho

  2026-08-03

  This article addresses key workflow challenges in phosphorylation analysis, demonstrating how Phos binding reagent (Phosbind) acrylamide (SKU F4002) streamlines SDS-PAGE detection of phosphorylated proteins without the need for antibodies. Scenario-driven guidance, protocol parameters, and literature-backed advice highlight its reliability and practical value for biomedical researchers.

• Viral Targeting of RIPK3 Regulates Necroptosis and Inflammat

  2026-08-03

  The referenced study identifies a viral mechanism whereby orthopoxviruses, such as cowpox virus, induce proteasomal degradation of the necroptosis adaptor RIPK3 to suppress host inflammatory responses. This finding clarifies how viral inhibitors modulate cell death pathways, with significant implications for understanding virus-induced pathogenesis and immune evasion.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Optimizing Dual Reporter mR

  2026-08-02

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5 fluorescence and EGFP expression to streamline mRNA delivery, tracking, and translation efficiency in advanced gene regulation workflows. Its immune-evasive chemistry and dual-reporter design empower direct, quantitative cellular analysis that surpasses conventional single-label systems.

• Ciprofloxacin Hydrochloride: Mechanism, Evidence, and Resear

  2026-08-01

  Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic with proven efficacy as a bacterial DNA replication inhibitor and immunomodulatory agent. Its benchmarked activity underpins FDA-approved anthrax treatment and advanced research on apoptosis modulation. This article details its mechanism, evidence, and research integration.

• Trelagliptin Succinate Improves Insulin Resistance via PI3K/

  2026-07-31

  This study demonstrates that trelagliptin succinate (SYR-472 succinate), a long-acting DPP-4 inhibitor, enhances insulin sensitivity in adipocytes by upregulating the PI3K/Akt/GLUT4 signaling pathway and reducing adipokine-mediated insulin resistance. These mechanistic insights broaden the understanding of DPP-4 inhibitors in type 2 diabetes research beyond glucose lowering alone.

• Anagliptin (SK-0403): Applied DPP-4 Inhibition in Vascular R

  2026-07-31

  Anagliptin (SK-0403) offers researchers a uniquely selective DPP-4 inhibitor for dissecting glycemic and vascular mechanisms. Its proven engagement with Kv channels and the SERCA pump provides new avenues for metabolic-cardiovascular interface studies, as well as troubleshooting guidance for assay optimization.

• ML385: Applied NRF2 Inhibitor Protocols for Cancer & Ferropt

  2026-07-30

  ML385, a selective NRF2 inhibitor from APExBIO, enables precise dissection of antioxidant signaling and therapeutic resistance in cancer and neurodegeneration models. Recent breakthroughs reveal how ML385 advances both oncology and ferroptosis research, with protocol-ready parameters and troubleshooting tips that streamline NRF2 pathway interrogation.

• Isoliensinine Modulates TRPV1–AMPK to Attenuate MAFLD Fibros

  2026-07-30

  This study reveals that isoliensinine from Plumula Nelumbinis significantly attenuates hepatic fibrosis in metabolic associated fatty liver disease (MAFLD) by restoring lipid droplet metabolism in hepatic stellate cells through TRPV1–AMPK/ACC pathway activation. The findings highlight a novel mechanism for energy metabolism regulation in liver fibrosis, with practical implications for metabolic disease research and anti-fibrotic strategy development.

8058 records 5/538 page Previous Next 12345 下5页 Last page